(State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) | ||||||
(Address of principal executive offices and zip) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
The Nasdaq Capital Market |
Dated: June 13, 2023 | POINT BIOPHARMA GLOBAL INC. | |||||||
By: | /s/ Bill Demers | |||||||
Name: | Bill Demers | |||||||
Title: | Chief Financial Officer |
Cover |
Jun. 12, 2023 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Document Period End Date | Jun. 12, 2023 |
Entity Registrant Name | POINT BIOPHARMA GLOBAL INC. |
Entity Incorporation, State or Country Code | DE |
Entity File Number | 001-39311 |
Entity Tax Identification Number | 85-0800493 |
Entity Address, Address Line One | 4850 West 78th Street |
Entity Address, City or Town | Indianapolis |
Entity Address, State or Province | IN |
Entity Address, Postal Zip Code | 46268 |
City Area Code | 317 |
Local Phone Number | 543-9957 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common stock, par value $0.0001 per share |
Trading Symbol | PNT |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Flag | false |
Entity Central Index Key | 0001811764 |
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